BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 99418)

  • 1. Bioavailability and pharmacokinetics of cefoxitin sodium.
    Schrogie JJ; Davies RO; Yeh KC; Rogers D; Holmes GI; Skeggs H; Martin CM
    J Antimicrob Chemother; 1978 Jul; 4(B):69-78. PubMed ID: 99418
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of lidocaine on the absorption, disposition and tolerance of intramuscularly administered cefoxitin.
    Sonneville PF; Albert KS; Skeggs H; Gentner H; Kwan KC; Martin CM
    Eur J Clin Pharmacol; 1977 Dec; 12(4):273-9. PubMed ID: 590313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefoperazone: absorption, excretion, distribution, and metabolism.
    Shimizu K
    Clin Ther; 1980; 3(Spec Issue):60-79. PubMed ID: 6446400
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of cefoxitin sodium in normal subjects and in uraemic patients.
    Fillastre JP; Leroy A; Godin M; Oksenhendler G; Humbert G
    J Antimicrob Chemother; 1978 Jul; 4(B):79-83. PubMed ID: 690027
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of orally administered probenecid on the pharmacokinetics of cefoxitin.
    Vlasses PH; Holbrook AM; Schrogie JJ; Rogers JD; Ferguson RK; Abrams WB
    Antimicrob Agents Chemother; 1980 May; 17(5):847-55. PubMed ID: 7396472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of cefuroxime and cefoxitin in experimentally induced pleurisy in the rat].
    Benoni G; Franco L; Conforti A; Totorizzo A; Velo GP
    G Ital Chemioter; 1981; 28(1-2):33-9. PubMed ID: 7347703
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of probenecid on the pharmacokinetics and distribution of cefoxitin in healthy volunteers.
    Reeves DS; Bullock DW; Bywater MJ; Holt HA; White LO; Thornhill DP
    Br J Clin Pharmacol; 1981 Apr; 11(4):353-9. PubMed ID: 7259928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and comparative pharmacology of cefoxitin and cephalosporins.
    Schrogie JJ; Rogers JD; Yeh KC; Davies RO; Holmes GI; Skeggs H; Martin CM
    Rev Infect Dis; 1979; 1(1):90-8. PubMed ID: 318227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal elimination of cefoxitin and effect of probenecid after single and repeated doses.
    Arvidsson A; BorgÄ O; Kager L; Pieper R
    J Antimicrob Chemother; 1981 Apr; 7(4):423-30. PubMed ID: 7019188
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced small intestinal absorption of cefmetazole and cefoxitin in rats in the presence of non-surfactant adjuvants.
    Nishihata T; Takahagi H; Higuchi T
    J Pharm Pharmacol; 1983 Feb; 35(2):124-5. PubMed ID: 6131983
    [No Abstract]   [Full Text] [Related]  

  • 11. Relevance of protein binding to cephalosporin antimicrobial activity in vivo.
    Mays B; Short L; Hershman MJ; Cheadle WG
    Chemotherapy; 1990; 36(4):254-8. PubMed ID: 2253496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of four cephalosporins into tissue fluid in man.
    Gillett AP; Wise
    Lancet; 1978 May; 1(8071):962-4. PubMed ID: 76892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of probenecid on serum cefoxitin concentrations.
    Bint AJ; Reeves DS; Holt HA
    J Antimicrob Chemother; 1977 Nov; 3(6):627-8. PubMed ID: 599129
    [No Abstract]   [Full Text] [Related]  

  • 14. Cephalexin.
    Griffith RS; Black HR
    Med Clin North Am; 1970 Sep; 54(5):1229-44. PubMed ID: 4248663
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study on the interstitial passage of cefuroxime, cefoxitin, cefotaxime and cefoperazone in man by the suction skin blister method.
    Frongillo RF; Galuppo L; Moretti A
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):412-6. PubMed ID: 6322818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of oral cephalosporins.
    Stoeckel K; Hayton WL; Edwards DJ
    Antibiot Chemother (1971); 1995; 47():34-71. PubMed ID: 8554307
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of adjuvants for enhancement of rectal absorption of cefoxitin in humans.
    Davis SS; Burnham WR; Wilson P; O'Brien J
    Antimicrob Agents Chemother; 1985 Aug; 28(2):211-5. PubMed ID: 3834830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of probenecid on disposition of cefpiramide in rat. The application of population pharmacokinetics.
    Yamaoka K; Yano Y; Sakurai O; Tanaka H
    Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):1196-200. PubMed ID: 3607942
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible mechanism behind the adjuvant action of phosphate derivatives on rectal absorption of cefoxitin in rats and dogs.
    Nishihata T; Lee CS; Nghiem BT; Higuchi T
    J Pharm Sci; 1984 Nov; 73(11):1523-5. PubMed ID: 6520749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics/pharmacodynamics of furosemide in man: a review.
    Benet LZ
    J Pharmacokinet Biopharm; 1979 Feb; 7(1):1-27. PubMed ID: 458552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.